Literature DB >> 31733318

Simple strategy for single-chain fragment antibody-conjugated probe construction.

Chen Xu1, Xiang Chen2, Mingjuan Yang2, Xiaopeng Yuan3, Aizhi Zhao4, Hujing Bao5.   

Abstract

AIMS: A combination of biomarker and instrument technology diagnosis methods, especially antigen-targeted imaging methods, is required to increase the accuracy of the diagnosis of cancer. Currently, the targeting efficiency is limited by the conjugation methods used for the conjugation of antibodies and imaging materials. Here, a simple strategy for the conjugation of a probe and a single-chain fragment antibody (scFv) that does not change the characteristics of the antibody was shown. MAIN
METHODS: An ScFv was conjugated with superparamagnetic iron oxide (SPIO) or indocyanine green (ICG) via a linker by utilizing the reaction between cysteine and maleimide. The characterization of the probe was performed by flow cytometry, confocal imaging, optical imaging and magnetic resonance imaging (MRI). KEY
FINDINGS: After conjugation, the scFv retained high affinity, antigen specificity, and strong internalization ability. The application of the conjugated probe was also confirmed by optical imaging and MRI. SIGNIFICANCE: The proposed strategy provides a simple method for the production of high efficiency antigen-targeted imaging probes for tumor diagnosis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ICG; Molecular imaging; SPIO; Tumor diagnosis; scFv

Mesh:

Substances:

Year:  2019        PMID: 31733318     DOI: 10.1016/j.lfs.2019.117052

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  Near-Infrared Fluorescence Imaging of EGFR-Overexpressing Tumors in the Mouse Xenograft Model Using scFv-IRDye800CW and Cetuximab-IRDye800CW.

Authors:  Abolfazl Amini; Yaghoub Safdari; Fatemeh Tash Shamsabadi
Journal:  Mol Imaging       Date:  2022-04-14       Impact factor: 3.250

2.  Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation.

Authors:  Zih-Chan Lin; Tsong-Long Hwang; Tse-Hung Huang; Kohei Tahara; Jiří Trousil; Jia-You Fang
Journal:  Theranostics       Date:  2021-03-04       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.